Literature DB >> 1623121

Anticoagulants from marine algae.

D S McLellan1, K M Jurd.   

Abstract

Anticoagulant properties were first described in extracts from marine algae over 50 years ago. Currently over 60 species, representing the three major divisions of marine algae, have been reported to have such properties. The major active components are a variety of sulphated polysaccharides, some of which characterize as proteoglycans. These sulphated polysaccharides/proteoglycans exert antithrombin properties, primarily mediated by heparin cofactor II (HCII). However antithrombin III (ATIII) mediated anticoagulant activities, as well as an element of direct antithrombin activity, have also been observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623121     DOI: 10.1097/00001721-199202000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  Inhibitory effects of Fucoidan in 3T3-L1 adipocyte differentiation.

Authors:  Mi-Ja Kim; Un-Jae Chang; Jin-Sil Lee
Journal:  Mar Biotechnol (NY)       Date:  2008-12-10       Impact factor: 3.619

2.  Novel sulfated polysaccharide derived from red-tide microalga Gyrodinium impudicum strain KG03 with immunostimulating activity in vivo.

Authors:  Joung Han Yim; Eunwha Son; Suhkneung Pyo; Hong Kum Lee
Journal:  Mar Biotechnol (NY)       Date:  2005-06-04       Impact factor: 3.619

3.  Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03.

Authors:  Joung Han Yim; Sung Jin Kim; Se Hun Ahn; Chong Kyo Lee; Ki Tae Rhie; Hong Kum Lee
Journal:  Mar Biotechnol (NY)       Date:  2003-09-29       Impact factor: 3.619

4.  Anti-wrinkle effects of Sargassum muticum ethyl acetate fraction on ultraviolet B-irradiated hairless mouse skin and mechanistic evaluation in the human HaCaT keratinocyte cell line.

Authors:  Jae Hyoung Song; Mei Jing Piao; Xia Han; Kyoung Ah Kang; Hee Kyoung Kang; Weon Jong Yoon; Mi Hee Ko; Nam Ho Lee; Mi Young Lee; Sungwook Chae; Jin Won Hyun
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.